Please use this identifier to cite or link to this item:
|Title:||Vegf Gene Polymorphisms And Outcome Of Epithelial Ovarian Cancer Patients|
Gabriela Ribeiro; Carvalho Brito
Angelo Borsarelli; Vassallo
Jose; Mauricette Derchain
Sophie Francoise; Passos Lima
|Abstract:||Since VEGF polymorphisms were associated with variable protein production, we analyzed herein their roles in outcome of epithelial ovarian cancer (EOC) patients. Methods: Genotypes of 85 patients with primary EOC were identified in DNA by real-time PCR. Progression-free survival and overall survival were analyzed using Kaplan-Meier method, univariate Cox model and bootstrap resampling study. Results: At 60 months of follow-up, progression-free survival was shorter in patients with VEGF c.-2578 CC genotype compared with others (52.7 vs 82.2%; p = 0.04). Those patients had 2.15 more chance of presenting disease progression than others (p = 0.04); bootstrap study validated the result (p = 0.03). Conclusion: Our data suggest that VEGF c.-2578C>A polymorphism acts as a prognostic factor in EOC.|
|Subject:||Epithelial Ovarian Cancer|
|Editor:||Future Medicine LTD|
|Citation:||Future Oncology. Future Medicine Ltd, v. 13, p. 409 - 414, 2017.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.